Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources

David J. Sullivan; Massimo Franchini; Michael J. Joyner; Arturo Casadevall; Daniele Focosi

doi:10.1038/s41467-022-33864-y

Nature Communications (Oct 2022)

Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources

David J. Sullivan,
Massimo Franchini,
Michael J. Joyner,
Arturo Casadevall,
Daniele Focosi

Affiliations

David J. Sullivan: Johns Hopkins Bloomberg School of Public Health and School of Medicine
Massimo Franchini: Division of Transfusion Medicine, Carlo Poma Hospital
Michael J. Joyner: Department of Anesthesiology & Perioperative Medicine, Mayo Clinic
Arturo Casadevall: Johns Hopkins Bloomberg School of Public Health and School of Medicine
Daniele Focosi: North-Western Tuscany Blood Bank, Pisa University Hospital

DOI: https://doi.org/10.1038/s41467-022-33864-y
Journal volume & issue: Vol. 13, no. 1
pp. 1 – 11

Abstract

Read online

Although COVID-19 convalescent plasma is commonly used for the treatment of immunosuppressed patients, this approach has yielded mixed results. Here, the authors present a systematic review of Omicron-neutralization data in convalescent plasma from vaccinated and unvaccinated individuals.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal